Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Petter Veiby currently holds 140,000 shares of Attovia Therapeutics, Inc. (ATTO), valued at approximately $0. This represents their equity stake as Chief Scientific Officer.
Based on SEC Form 4 filings, Petter Veiby has been a net neutral trader of ATTO stock. They have purchased $0 and sold $0 worth of shares.
Petter Veiby's most recent insider trade was on Aug 4, 2026, when they sold 140,000 shares at $0.00 per share.
Petter Veiby serves as Chief Scientific Officer at Attovia Therapeutics, Inc. (ATTO). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Petter Veiby holds the position of Chief Scientific Officer at Attovia Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Petter Veiby has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Petter Veiby was on Aug 4, 2026, when they purchased $0 worth of ATTO shares. This transaction involved 140,000 shares at N/A per share.
Petter Veiby currently owns 140,000 shares of Attovia Therapeutics, Inc. (ATTO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Petter Veiby's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Petter Veiby has 1 Form 4 filings on record as an insider at Attovia Therapeutics, Inc..
Set alerts for Petter Veiby and 40,000+ other insiders.